Daria G. Husni
Advertisement
Daria G. Husni is Assistant Editor for BioPharm International.
Articles by Daria G. Husni
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Iovance’s Lifileucel Reaches 52% Response Rate in Biomarker-Selected Lung Cancer Subgroup
2
Lilly’s Retatrutide Doubles Ozempic’s Weight Loss in First Phase 3 Head-to-Head Trial
3
AbbVie Files BLA With FDA for Etentamig in Relapsed/Refractory Myeloma
4
The BioPharm Brief: A Survival Win, a Myeloma Filing, and Gene Therapy for Swallowing
5